827
Participants
Start Date
December 31, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
TAK-438
TAK-438 10 mg, tablets, orally, once daily for 4 weeks. Thereafter, TAK-438 placebo tablets, orally, once daily for 1 week.
TAK-438
TAK-438 20 mg, tablets, orally, once daily for 4 weeks. Thereafter, TAK-438 placebo tablets, orally, once daily for 1 week.
Placebo
TAK-438 placebo-matching tablets, orally, once daily for 5 weeks.
Nagoya
Abiko-shi
Kashiwa-shi
Noda
Yachiyo-shi
Saijo-shi
Fukuoka
Itoshima-shi
Kasuya-gun
Onga-gun
Kouriyama-shi
Gifu
Takayama-shi
Annaka-shi
Hiroshima
Asahikawa-shi
Sapporo
Amagasaki-shi
Kobe
Nishinomiya-shi
Takarazuka-shi
Sagamihara-shi
Yokohama
Kochi
Suzaki-shi
Kumamoto
Kyoto
Sendai
Nagasaki
Ōita
Okayama
Osaka
Takatsuki-shi
Saga
Kumagaya-shi
Saitama-shi
Tokorozawa-shi
Otawara-shi
Bunkyo-ku
Chiyoda-ku
Chuo-ku
Hachioji-shi
Kokubunji-shi
Nakano-ku
Oota-ku
Setagaya-ku
Shibuya-ku
Shinjuku-ku
Shimonoseki-shi
Kofu
Turu-shi
Yamagata
Lead Sponsor
Takeda
INDUSTRY